Skip to main content

Diagnostic options ยท UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00โ€“50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 31โ€“45 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-3735
ABCD1 Gene Sequencing for Adrenoleukodystrophy & Adrenomyeloneuropathy (NGS) Test

This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD) and adrenomyeloneuropathy (AMN). It provides definitive molecu...

Peripheral Whole Blood (EDTA) 21โ€“28 Days (3โ€“4 Weeks) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ABCD1 gene", "Copy Number Variants (CNVs) in ABCD1"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medication use"]
Indications
["Confirmation of suspected X-ALD/AMN", "Identification of asymptomatic carriers", "Genetic counseling for affected families", "Pre-implantation genetic diagnosis (PGD) or prenatal diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 64579-6 ICD-10: E71.520
Clinical summary
This test analyzes the ABCD1 gene to detect pathogenic variants associated with X-linked adrenoleukodystrophy (X-ALD) and adrenomyeloneuropathy (AMN). It provides definitive molecular confirmation, identifies carriers, and informs treatment decisions.
TEST-6138
ABCD3 Gene Bile Acid Synthesis Defect Type 5, Congenital Genetic Test

This test evaluates the ABCD3 gene for pathogenic variants associated with congenital bile acid synthesis defect type 5.

Peripheral whole blood 3-4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABCD3 gene coding region", "Pathogenic variants"]
Parameters
[]
Preparation
["Attend a pre-test genetic counseling session", "No fasting required unless specified by phlebotomist"]
Indications
["Suspected congenital bile acid synthesis defect type 5", "Neonatal cholestasis of unknown origin", "Family history of peroxisomal disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: E71.5
Clinical summary
This test evaluates the ABCD3 gene for pathogenic variants associated with congenital bile acid synthesis defect type 5.
TEST-6056
ABHD1 Gene Lung Alpha-Beta Hydrolase Deficiency Type 1 Genetic Test

This genetic test identifies pathogenic variants in the ABHD1 gene associated with lung alpha-beta hydrolase deficiency type 1.

Peripheral whole blood (4 mL EDTA) 21โ€“28 calendar days (expedited 14-day option available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABHD1 gene coding region variants", "ABHD1 gene splice site variants"]
Parameters
[]
Preparation
["No fasting required", "No special preparation required"]
Indications
["Diagnosis of ABHD1 gene-related lung alpha-beta hydrolase deficiency type 1", "Family counselling for ABHD1-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: E78.89
Clinical summary
This genetic test identifies pathogenic variants in the ABHD1 gene associated with lung alpha-beta hydrolase deficiency type 1.
TEST-6189
ABHD5 Gene Chanarin-Dorfman Syndrome Genetic Test

This test analyzes the ABHD5 gene to identify mutations causing Chanarin-Dorfman syndrome, a rare inherited metabolic disorder.

Peripheral Whole Blood (EDTA) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ABHD5 gene sequence", "Point mutations", "Small insertions/deletions", "Splice-site variants"]
Parameters
[]
Preparation
["Documented clinical history", "Mandatory genetic counselling session", "Valid informed consent"]
Indications
["Suspected Chanarin-Dorfman syndrome", "Family history of Chanarin-Dorfman syndrome", "Asymptomatic siblings of confirmed cases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81290-9 ICD-10: E75.5, Z14.8, Z13.228
Clinical summary
This test analyzes the ABHD5 gene to identify mutations causing Chanarin-Dorfman syndrome, a rare inherited metabolic disorder.
TEST-6045
ACACA Gene Acetyl-CoA Carboxylase Deficiency Genetic Test

This genetic test analyzes the ACACA gene for variants associated with Acetyl-CoA Carboxylase Deficiency.

Peripheral whole blood 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACACA gene", "Fatty acid biosynthesis pathway"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counseling session provided"]
Indications
["Suspected Acetyl-CoA Carboxylase Deficiency", "Family history of metabolic disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 102361-9 ICD-10: E88.8
Clinical summary
This genetic test analyzes the ACACA gene for variants associated with Acetyl-CoA Carboxylase Deficiency.
TEST-6095
ACAD8 Gene Isobutyryl-CoA Dehydrogenase Deficiency Genetic Test

This genetic test evaluates the ACAD8 gene for pathogenic variants associated with isobutyryl-CoA dehydrogenase deficiency.

Peripheral Whole Blood (EDTA) 3 โ€“ 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACAD8 gene", "Isobutyryl-CoA dehydrogenase deficiency"]
Parameters
[]
Preparation
["Attend a mandatory genetic counseling session", "Provide a detailed family pedigree chart"]
Indications
["Clinical diagnosis of isobutyryl-CoA dehydrogenase deficiency", "Carrier status determination", "Reproductive risk assessment"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21619-4 ICD-10: E71.121
Clinical summary
This genetic test evaluates the ACAD8 gene for pathogenic variants associated with isobutyryl-CoA dehydrogenase deficiency.
TEST-6058
ACADS Gene (Acyl-CoA Short-Chain Dehydrogenase Deficiency) Genetic Test

This diagnostic test evaluates the ACADS gene for mutations associated with short-chain acyl-CoA dehydrogenase deficiency (SCADD).

Peripheral Whole Blood 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ACADS gene mutations", "Single nucleotide variants", "Indels", "Copy number changes"]
Parameters
[{"name": "Analytical Sensitivity", "reference_range": ">99.9% for single nucleotide variants, indels, and copy number changes"}]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"]
Indications
["Suspected SCADD based on clinical symptoms", "Family history of SCADD", "Metabolic crisis", "Guidance for dietary management", "Family planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81305-9 ICD-10: E71.31
Clinical summary
This diagnostic test evaluates the ACADS gene for mutations associated with short-chain acyl-CoA dehydrogenase deficiency (SCADD).
TEST-6053
ACAT1 Gene Methylacetoacetic Aciduria Genetic Test

This test evaluates the ACAT1 gene for pathogenic variants associated with methylacetoacetic aciduria (beta-ketothiolase deficiency). It utilizes next-generation sequencing to anal...

Peripheral Whole Blood (EDTA tube) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACAT1 gene", "Single-nucleotide variants (SNVs)", "Insertions/Deletions (Indels)", "Copy-number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "No specific medication or diet instructions needed prior to sample collection"]
Indications
["Individuals with unexplained episodes of metabolic acidosis, ketosis, vomiting, or lethargy", "Siblings of affected children", "Parents interested in carrier screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101401-4 ICD-10: E71.1
Clinical summary
This test evaluates the ACAT1 gene for pathogenic variants associated with methylacetoacetic aciduria (beta-ketothiolase deficiency). It utilizes next-generation sequencing to analyze the entire coding region.
TEST-5231
ACD Gene Dyskeratosis Congenita, Autosomal Recessive Type 7 (DKC7) Genetic Test

This genetic test evaluates the ACD gene for pathogenic variants associated with Dyskeratosis Congenita type 7, a disorder affecting telomere maintenance.

Peripheral Whole Blood 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACD gene", "Single Nucleotide Variants (SNVs)", "Copy Number Variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medication without consulting specialist"]
Indications
["Suspected Dyskeratosis Congenita", "Family history of Dyskeratosis Congenita", "Evaluation of bone marrow failure", "Assessment of cancer predisposition"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 102578-5 ICD-10: Q82.8, D61.09, Z15.89
Clinical summary
This genetic test evaluates the ACD gene for pathogenic variants associated with Dyskeratosis Congenita type 7, a disorder affecting telomere maintenance.
TEST-3528
ACE Gene Renal Tubular Dysgenesis Genetic Test

This genetic test identifies mutations in the ACE gene associated with autosomal recessive renal tubular dysgenesis.

Peripheral Whole Blood 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACE gene", "Autosomal recessive inheritance patterns"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any relevant family history"]
Indications
["Family history of unexplained neonatal renal failure", "Suspected autosomal recessive renal tubular dysgenesis", "Carrier screening in families with affected individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: Q61.4
Clinical summary
This genetic test identifies mutations in the ACE gene associated with autosomal recessive renal tubular dysgenesis.
TEST-1876
Achondroplasia (FGFR3 Full Gene Sequence Analysis) Test

This test analyzes the entire FGFR3 gene sequence to detect mutations associated with achondroplasia and related skeletal dysplasias.

Amniotic Fluid, Chorionic Villi, or Cord Blood 14โ€“21 business days 4,000.00 AED
View
View test specifications and preparation
What it measures
["FGFR3 gene sequence", "Pathogenic variants in FGFR3"]
Parameters
[]
Preparation
["Valid physician referral required", "Consult treating physician before altering medication or surgical plans"]
Indications
["Suspected achondroplasia", "Suspected hypochondroplasia", "Prenatal diagnosis of FGFR3-related skeletal dysplasias", "Pre-implantation genetic diagnosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21669-6 ICD-10: Q77.4
Clinical summary
This test analyzes the entire FGFR3 gene sequence to detect mutations associated with achondroplasia and related skeletal dysplasias.
TEST-3542
ACO2 Gene Cerebellar-Retinal Degeneration, Infantile Genetic Test

This test identifies mutations in the ACO2 gene associated with infantile cerebellar-retinal degeneration.

Whole Blood (EDTA tube, 3โ€“5 mL) 3โ€“4 Weeks (21โ€“28 calendar days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["ACO2 gene sequence", "Mutations in the ACO2 gene"]
Parameters
[]
Preparation
["No fasting required", "Standard infant handling procedures"]
Indications
["Infants with clinical suspicion of infantile cerebellar-retinal degeneration", "Family history of ACO2-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G31.84, H35.5
Clinical summary
This test identifies mutations in the ACO2 gene associated with infantile cerebellar-retinal degeneration.
TEST-4538
ACP5 Gene Spondyloenchondrodysplasia with Immune Dysregulation Test

This test evaluates the ACP5 gene for pathogenic variants associated with Spondyloenchondrodysplasia with Immune Dysregulation (SPENCDI). It uses Next Generation Sequencing (NGS) t...

2 mL Peripheral Whole Blood (EDTA tube) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACP5 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number variations (CNV)"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of ACP5-related disease", "Confirmed family history of ACP5-related disease"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92734-4 ICD-10: M89.88
Clinical summary
This test evaluates the ACP5 gene for pathogenic variants associated with Spondyloenchondrodysplasia with Immune Dysregulation (SPENCDI). It uses Next Generation Sequencing (NGS) to detect single nucleotide variants, small insertions/deletions, and copy number variations.
TEST-6125
ACSF3 Gene Test for Combined Malonic and Methylmalonic Aciduria (NGS)

This test identifies pathogenic variants in the ACSF3 gene associated with Combined Malonic and Methylmalonic Aciduria.

Peripheral whole blood (or tissue biopsy) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["ACSF3 gene pathogenic variants", "Combined Malonic and Methylmalonic Aciduria genetic predisposition"]
Parameters
[]
Preparation
["No specific fasting required", "Do not discontinue prescribed medications or supplements"]
Indications
["Suspected Combined Malonic and Methylmalonic Aciduria", "Family history of the disorder", "Carrier screening", "Peace-of-mind testing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101872-5 ICD-10: E71.120, E71.1, Z13.79
Clinical summary
This test identifies pathogenic variants in the ACSF3 gene associated with Combined Malonic and Methylmalonic Aciduria.
TEST-5046
ACSL4 Gene X-linked Intellectual Disability Type 63 (MRX63) Genetic Test

This genetic test identifies pathogenic variants within the ACSL4 gene, confirming a diagnosis of X-linked intellectual disability type 63 (MRX63).

Peripheral Whole Blood 3โ€“4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the ACSL4 gene", "Single nucleotide variants", "Small insertions and deletions (indels)"]
Parameters
[]
Preparation
["Pre-test genetic counseling session required", "No specific fasting or medication adjustments needed"]
Indications
["Males with intellectual disability of unknown cause", "Suspected X-linked inheritance pattern", "Assessing potential female carriers in families with known or suspected ACSL4 mutation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 101143-9 ICD-10: F78
Clinical summary
This genetic test identifies pathogenic variants within the ACSL4 gene, confirming a diagnosis of X-linked intellectual disability type 63 (MRX63).

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area